Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)

Abstract

INTRODUCTION The 'Study of Intravenous Autologous Marrow in Multiple Sclerosis (SIAMMS)' trial was a safety and feasibility study which examined the effect of intravenous infusion of autologous bone marrow without myeloablative therapy. This trial was well tolerated and improvement was noted in the global evoked potential (GEP)--a neurophysiological… (More)
DOI: 10.1136/bmjopen-2015-009090

Topics

2 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics